Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American family
Hypokalaemic periodic paralysis (HypoPP) is an autosomal dominant disorder, which is characterized by periodic attacks of muscle weakness associated with a decrease in the serum potassium level. A major disease-causing gene for HypoPP has been identified as CACNA1S, which encodes the skeletal muscle...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2009
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22368
- Acceso en línea:
- https://doi.org/10.1038/jhg.2009.92
https://repository.urosario.edu.co/handle/10336/22368
- Palabra clave:
- Calcium channel
Genomic dna
Membrane protein
Adolescent
Adult
Alpha chain
Article
Autosomal dominant inheritance
Cacna1s gene
Child
Clinical article
Controlled study
Dna isolation
Dna sequence
Female
Gene
Gene mutation
Genetic analysis
Human
Hypokalemic periodic paralysis
Male
Muscle weakness
Potassium blood level
Preschool child
Prognosis
Protein domain
School child
Skeletal muscle
South america
Amino acid sequence
Base sequence
Calcium channels
Colombia
Dna mutational analysis
Family health
Female
Humans
Hypokalemic periodic paralysis
Male
Molecular sequence data
Mutation
Pedigree
Cacna1s
Hypokalaemic periodic paralysis
Mutation
dominant
Genes
- Rights
- License
- Abierto (Texto Completo)
Summary: | Hypokalaemic periodic paralysis (HypoPP) is an autosomal dominant disorder, which is characterized by periodic attacks of muscle weakness associated with a decrease in the serum potassium level. A major disease-causing gene for HypoPP has been identified as CACNA1S, which encodes the skeletal muscle calcium channel ?-subunit with four transmembrane domains (I-IV), each with six transmembrane segments (S1-S6). To date, all CACNA1S mutations identified in HypoPP patients are located within the voltage-sensor S4 segment. In this study we report a novel CACNA1S mutation in a new region of the protein, the S3 segment of domain III. We characterized a four-generation South American family with HypoPP. Genetic analysis identified a novel V876E mutation in all HypoPP patients in the family, but not in normal family members or 160 control people. Clinical analysis indicates that mutation V876E is associated with a severe outcome as characterized by a very early age of onset, complete penetrance and a severe prognosis including death. These results identify a new mutation in CACNA1S and expand the spectrum of CACNA1S mutations associated with HypoPP. © 2009 The Japan Society of Human Genetics All rights reserved. |
---|